» Articles » PMID: 10543745

Diversity of TEM Mutants in Proteus Mirabilis

Overview
Specialty Pharmacology
Date 1999 Oct 30
PMID 10543745
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

In a survey of resistance to amoxicillin among clinical isolates of Proteus mirabilis, 10 TEM-type beta-lactamases were characterized: (i) the well-known penicillinases TEM-1 and TEM-2, the extended-spectrum beta-lactamases (ESBLs) TEM-3 and TEM-24, and the inhibitor-resistant TEM (IRT) TEM-44 and (ii) five novel enzymes, a penicillinase TEM-57 similar to TEM-1, an ESBL TEM-66 similar to TEM-3, and three IRTs, TEM-65, TEM-73, and TEM-74. The penicillinase TEM-57 and the ESBL TEM-66 differed from TEM-1 and TEM-3, respectively, by the amino acid substitution Gly-92-->Asp (nucleotide mutation G-477-->A). This substitution could have accounted for the decrease in pIs (5.2 for TEM-57 and 6.0 for TEM-66) but did not necessarily affect the intrinsic activities of these enzymes. The IRT TEM-65 was an IRT-1-like IRT (Cys-244) related to TEM-2 (Lys-39). The two other IRTs, TEM-73 and TEM-74, were related to IRT-1 (Cys-244) and IRT-2 (Ser-244), respectively, and harbored the amino acid substitutions Leu-21-->Phe and Thr-265-->Met. In this study, the ESBLs TEM-66, TEM-24, and TEM-3 were encoded by large (170- to 180-kb) conjugative plasmids that exhibited similar patterns after digestion and hybridization with the TEM and AAC(6')I probes. The three IRTs TEM-65, TEM-73, and TEM-74 were encoded by plasmids that ranged in size from 42 to 70 kb but for which no transfer was obtained. The characterization of five new plasmid-mediated TEM-type beta-lactamases and the first report of TEM-24 in P. mirabilis are evidence of the wide diversity of beta-lactamases produced in this species and of its possible role as a beta-lactamase-encoding plasmid reservoir.

Citing Articles

Antibiotic resistance and virulence profiles of Proteus mirabilis isolated from broiler chickens at abattoir in South Africa.

Ramatla T, Ramaili T, Lekota K, Mileng K, Ndou R, Mphuthi M Vet Med Sci. 2024; 10(2):e1371.

PMID: 38357843 PMC: 10867704. DOI: 10.1002/vms3.1371.


Regulatory Mechanisms of the LuxS/AI-2 System and Bacterial Resistance.

Wang Y, Liu B, Grenier D, Yi L Antimicrob Agents Chemother. 2019; 63(10).

PMID: 31383657 PMC: 6761564. DOI: 10.1128/AAC.01186-19.


Genetic markers associated with resistance to beta-lactam and quinolone antimicrobials in non-typhoidal isolates from humans and animals in central Ethiopia.

Eguale T, Birungi J, Asrat D, Njahira M, Njuguna J, Gebreyes W Antimicrob Resist Infect Control. 2017; 6:13.

PMID: 28105330 PMC: 5240271. DOI: 10.1186/s13756-017-0171-6.


TEM-187, a new extended-spectrum β-lactamase with weak activity in a Proteus mirabilis clinical strain.

Corvec S, Beyrouthy R, Cremet L, Aubin G, Robin F, Bonnet R Antimicrob Agents Chemother. 2013; 57(5):2410-2.

PMID: 23478954 PMC: 3632918. DOI: 10.1128/AAC.01761-12.


International spread and persistence of TEM-24 is caused by the confluence of highly penetrating enterobacteriaceae clones and an IncA/C2 plasmid containing Tn1696::Tn1 and IS5075-Tn21.

Novais A, Baquero F, Machado E, Canton R, Peixe L, Coque T Antimicrob Agents Chemother. 2009; 54(2):825-34.

PMID: 19995930 PMC: 2812134. DOI: 10.1128/AAC.00959-09.


References
1.
Sirot D, Chanal C, Henquell C, Labia R, Sirot J, CLUZEL R . Clinical isolates of Escherichia coli producing multiple TEM mutants resistant to beta-lactamase inhibitors. J Antimicrob Chemother. 1994; 33(6):1117-26. DOI: 10.1093/jac/33.6.1117. View

2.
Sirot D, Recule C, Chaibi E, Bret L, Croize J, Labia R . A complex mutant of TEM-1 beta-lactamase with mutations encountered in both IRT-4 and extended-spectrum TEM-15, produced by an Escherichia coli clinical isolate. Antimicrob Agents Chemother. 1997; 41(6):1322-5. PMC: 163908. DOI: 10.1128/AAC.41.6.1322. View

3.
Vedel G, Belaaouaj A, Gilly L, Labia R, Philippon A, Nevot P . Clinical isolates of Escherichia coli producing TRI beta-lactamases: novel TEM-enzymes conferring resistance to beta-lactamase inhibitors. J Antimicrob Chemother. 1992; 30(4):449-62. DOI: 10.1093/jac/30.4.449. View

4.
Sirot D, Sirot J, Labia R, Morand A, Courvalin P, Darfeuille-Michaud A . Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel beta-lactamase. J Antimicrob Chemother. 1987; 20(3):323-34. DOI: 10.1093/jac/20.3.323. View

5.
Chanal C, Sirot D, Petit A, Labia R, Morand A, Sirot J . Multiplicity of TEM-derived beta-lactamases from Klebsiella pneumoniae strains isolated at the same hospital and relationships between the responsible plasmids. Antimicrob Agents Chemother. 1989; 33(11):1915-20. PMC: 172787. DOI: 10.1128/AAC.33.11.1915. View